|
1
|
Herszényi L and Tulassay Z: Epidemiology
of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci.
14:249–258. 2010.PubMed/NCBI
|
|
2
|
Napier KJ, Scheerer M and Misra S:
Esophageal cancer: A Review of epidemiology, pathogenesis, staging
workup and treatment modalities. World J Gastrointest Oncol.
6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang HZ, Jin GF and Shen HB:
Epidemiologic differences in esophageal cancer between Asian and
Western populations. Chin J Cancer. 31:281–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu J, Xie X, Zhou C, Peng S, Rao D and Fu
J: Which factors are associated with actual 5-year survival of
oesophageal squamous cell carcinoma? Eur J Cardiothorac Surg.
41:e7–e11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O'Malley MA, Elliott KC and Burian RM:
From genetic to genomic regulation: Iterativity in microRNA
research. Stud Hist Philos Biol Biomed Sci. 41:407–417. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guarnieri DJ and DiLeone RJ: MicroRNAs: A
new class of gene regulators. Ann Med. 40:197–208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ,
Wang TY, Li HC and Wu XN: Differential expression of miRNAs in
esophageal cancer tissue. Oncol Lett. 5:1639–1642. 2013.PubMed/NCBI
|
|
8
|
Gu J, Wang Y and Wu X: MicroRNA in the
pathogenesis and prognosis of esophageal cancer. Curr Pharm Des.
19:1292–1300. 2013.
|
|
9
|
Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X,
Zhang Y, Chen X, Wang J, Zen K, et al: Diagnostic and prognostic
implications of a serum miRNA panel in oesophageal squamous cell
carcinoma. PLoS One. 9:e922922014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang XF, Shi ZM, Wang XR, Cao L, Wang YY,
Zhang JX, Yin Y, Luo H, Kang CS, Liu N, et al: MiR-181d acts as a
tumor suppressor in glioma by targeting K-ras and Bcl-2. J Cancer
Res Clin Oncol. 138:573–584. 2012. View Article : Google Scholar
|
|
11
|
Zhang W, Zhang J, Hoadley K, Kushwaha D,
Ramakrishnan V, Li S, Kang C, You Y, Jiang C, Song SW, et al:
miR-181d: A predictive glioblastoma biomarker that downregulates
MGMT expression. Neurooncol. 14:712–719. 2012.
|
|
12
|
Guo Y, Chen Z, Zhang L, Zhou F, Shi S,
Feng X, Li B, Meng X, Ma X, Luo M, et al: Distinctive microRNA
profiles relating to patient survival in esophageal squamous cell
carcinoma. Cancer Res. 68:26–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang F, Olson EM and Shyng SL: Role of
Derlin-1 protein in proteostasis regulation of ATP-sensitive
potassium channels. J Biol Chem. 287:10482–10493. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen SF, Wu CH, Lee YM, Tam K, Tsai YC,
Liou JY and Shyue SK: Caveolin-1 interacts with Derlin-1 and
promotes ubiquitination and degradation of cyclooxygenase-2 via
collaboration with p97 complex. J Biol Chem. 288:33462–33469. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tan X, He X, Jiang Z, Wang X, Ma L, Liu L,
Wang X, Fan Z and Su D: Derlin-1 is overexpressed in human colon
cancer and promotes cancer cell proliferation. Mol Cell Biochem.
408:205–213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ran Y, Hu H, Hu D, Zhou Z, Sun Y, Yu L,
Sun L, Pan J, Liu J, Liu T, et al: Derlin-1 is overexpressed on the
tumor cell surface and enables antibody-mediated tumor targeting
therapy. Clin Cancer Res. 14:6538–6545. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong QZ, Wang Y, Tang ZP, Fu L, Li QC,
Wang ED and Wang EH: Derlin-1 is overexpressed in non-small cell
lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated
up-regulation of MMP-2 and MMP-9. Am J Pathol. 182:954–964. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu L, Wang ZH, Xu D, Lin G, Li DR, Wan T
and Guo SL: Expression of Derlin-1 and its effect on expression of
autophagy marker genes under endoplasmic reticulum stress in lung
cancer cells. Cancer Cell Int. 14:502014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Motoyama K, Inoue H, Takatsuno Y, Tanaka
F, Mimori K, Uuetake H, Sugihara K and Mori M: Over- and
under-expressed microRNAs in human colorectal cancer. Int J Oncol.
34:1069–1075. 2009.PubMed/NCBI
|
|
20
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar
|
